Pricing

Pay per feasibility memo

Each memo is a computational go/no-go assessment of one target — the work a team would otherwise spend weeks assembling. Start with free evaluation reports; buy credits when you need a memo you can act on.

Starter

Self-serve credits

Academic & pre-seed. Start with 3 free reports, then buy credits.

  • · Full memo (PDF + JSON)
  • · Automated quality self-check
  • · AI scientific review
  • · Credits never expire
Most common
Growth

Funded biotech

Series A–B. Volume pricing, priority turnaround, and a walkthrough with the team.

  • · From $3,000 / report (volume)
  • · Priority support + turnaround
  • · Design walkthrough call
  • · Annual programme retainer available
Contact sales →
Enterprise

Pharma / CRO

Portfolio-scale, integrated, and contracted.

  • · $80k–150k / year
  • · Unlimited reports + API access
  • · White-label option
  • · Calibration / outcome feedback loop
  • · MSA + data-rights agreement
Contact sales →

The memo is a computational feasibility study from public data — a go/no-go decision aid, not an IND-enabling package or wet-lab result. All findings require experimental confirmation. Acceptance of the Terms of Service is required before generating a report.

Legal & policies · Privacy · Refunds & billing · Acceptable use